Puerarin is the major bioactive ingredient derived from the root of the Pueraria lobata (Willd.), and its antioxidative stress effects have been demonstrated in several previous studies. Moreover, Puerarin can upregulate melanin synthesis and microphthalmia-associated transcription factor (MITF) transcription by increasing cAMP level of intracellular cyclic adenosine monophosphate. Vitiligo is an acquired cutaneous disorder of pigmentation, and the pathogenesis has remained elusive.
associated transcription factor (MITF) was an important transcription factor in melanogenesis, which could upregulate TYR and TRP-1 protein expression, thereby promoting the formation of melanin (Levy, Khaled, & Fisher, 2006) . The mitogen-activated protein kinases (MAPKs) are key signaling molecules related to the regulation of melanogenesis (Zhou, Shang, Ping, & Zhao, 2012) , including extracellular signal-regulating kinase (ERK), stress-activated protein kinase (SAPK)/JNK, and p38 mitogen-activated protein kinase (p38 MAPK) signaling cascades. Previous literature showed that phosphorylation of p38 can lead to the activation of MITF via the phosphorylation of cyclic adenosinemonophosphate (cAMP) responsive element binding protein (Su et al., 2013) . The activated ERK1/2 could induce the phosphorylation of MITF, which was followed by MITF ubiquitination and degradation. Furthermore, p38 has been shown to be involved in ultraviolet radiation-induced melanogenesis via activation of MITF and subsequent increased TYR expression (Levy et al., 2006) . Current treatment modalities were directed towards stopping progression of the disease and achieving repigmentation. Therapies included corticosteroids, topical immunomodulators, photo(chemo)therapy, surgery, combination therapies, and depigmentation of normally pigmented skin (Speeckaert & van Geel, 2017) . The current treatment methods are not yet satisfactory, so new and effective treatments are very necessary. Puerarin is the major bioactive ingredient derived from the root of the Pueraria lobata (Willd.), which is widely known as Gegen (Chinese name) in traditional Chinese medicine (Zeng et al., 2018; Zhou, Zhang, & Peng, 2014) . The anti-inflammatory property of puerarin was verified in several cellular models of inflammation (Hu et al., 2011; Huang, Liu, Du, Kou, & Liu, 2012; Wu et al., 2016; Yang, Hu, Zhang, Wang, & Sun, 2010) . Moreover, puerarin can block oxidative stress and resist against cellular oxidative injury (Hwang & Jeong, 2008; Yang, Lou, & Wang, 2009 ). Additionally, puerarin can upregulate melanin synthesis and MITF transcription by increasing cAMP level of intracellular cyclic adenosine monophosphate (Park, Kwon, Yoon, & Chung, 2014) . Further, it also has been reported that puerarin could regulate MAPK pathways (Wu et al., 2016) . Thus, we speculated that puerarin might influence melanin biosynthesis by regulating MITF, TYR, and TRP-1 expression via MAPK pathway (p38, ERK, and JNK). Further, there is no research on the therapeutic effect of puerarin on vitiligo mice. Therefore, in this study, we investigated the effects and the underlying mechanism of puerarin in human melanocytes and the protective role of puerarin in mice vitiligo models.
| MATERIALS AND METHODS

| Materials
The puerarin (purity > 98.5%), dispase II, growth medium M-254, human melanocyte growth supplement-2, and L-3,4-dihydroxyphenylalanine (L-DOPA) were purchased from Sigma Chemical Co (St. Louis, MO, USA). Puerarin was dissolved in sterile phosphate buffered saline (PBS; cell experiment). Cell Counting Kit-8 (CCK-8) was purchased from Dojindo (Kumamoto, Japan). Primary antibodies against ERK1/2, phospho-ERK1/2 (p-ERK1/2), JNK, phospho-JNK (p-JNK), p38, phospho-p38 (pp38), MITF, TRP-1, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were purchased from Abcam (Cambridge, MA, USA). Goat antirabbit and goat antimouse horseradish peroxidase conjugates were purchased from Bio-Rad Laboratories (CA, USA).
| Separation and cultivation of melanocytes from human foreskins
The methods have been described before (Böttcher-Haberzeth et al., 2014) . In brief, human foreskins from circumcision were washed in cold-buffered penicillin (500 IU/ml) and streptomycin (500 mg/ml), and then the subcutaneous fat and deep dermis were carefully removed.
The foreskins were cut into small pieces and incubated in dispase II (2 mg/ml) at 4°C for 16-18 hr. The epidermal layer was mechanically separated from the dermis and digested in 0.25% trypsin/EDTA solution at 37°C for 15 min. After incubation, the epidermis was aspirated with a plastic pipette for 20 times in order to properly dissociate the cells and then centrifuged at 1,000 rpm for 5 min, and the supernatant was discarded. The inner cell mass was obtained and suspended in the M254 supplemented with 1% human melanocyte growth supplement-2. Finally, cells were plated at a density of 1 × 10 5 cells/ml in tissue culture flasks and incubated in a humidified atmosphere of 5% CO 2 at 37°C. The media were changed after 24 hr and thereafter every 2-3 days. Cells were passaged when at 80% to 90% confluence using 0.25% trypsin/EDTA solution. Passages 3 to 5 were used in our study.
| Identification of melanocytes by DOPA staining
Melanocytes were identified by L-DOPA staining. The detailed steps were as follows. The cell climbing slice was prepared and was washed with PBS, followed by being fixed with 4% paraformaldehyde for 10 min at room temperature and washed with PBS again, repeated three times. The slice was incubated in L-DOPA staining solution (Shanghai Sangon Biological Engineering Co., Ltd., Shanghai, China) for 4 hr at 37°C and then washed with water for 5 min. The slice was then observed under transmission electron microscope.
| CCK-8 assay for measurement of cell proliferation
The proliferation of cells was determined by the CCK-8 assay (Huang et al., 2014) . Briefly, cells were seeded at density of 10 4 cells per well and cultured in 96-well flat-bottomed microplates in a supplemented M-254 growth medium and incubated at 37°C and 5% CO 2 for 48 hr. Then, the medium was removed, and the solutions containing different concentrations of puerarin (range from 1 to 160 uM) were added to the wells, and the cells were cultured for another 24 hr.
CCK-8 reagent (10 μl) was added to each well of a 96-well flatbottomed microplate containing 100 μl of culture medium to a final concentration of 10 μl/100 μl and incubated for an additional 4 hr at 37°C and 5% CO 2 . The absorbance rate was measured at 450 nm repeatedly by automicroplate reader (Bio-Rad, USA). The controls (the same cells but not treated with puerarin) were normalized to 100% for each assay, and treatments were expressed as the percentage of the controls. All experiments were performed in quintuplicate on three separate occasions, and the data were collected when the OD value of the control group is close to 1.
| Melanin content assay
Melanin content was measured as described previously (Hwang, Kuo, Lin, & Kao, 2013) . The human melanocytes were seeded in T-25
flasks at a density of 1 × 10 5 cells per flask. The cells were exposed to puerarin after 48-hr seeding. After another 24 hr of incubation with puerarin, the cells were detached with trypsin/EDTA and then centrifuged at 1,000 rpm for 5 min, and the supernatant was discarded. The inner cell mass was obtained and suspended in the PBS, and the cell counting was performed. Afterwards, the cell suspension was centrifuged under the equivalent condition again, and the cell pellets were placed into Eppendorf tubes, dissolved in 100 μl of 1-mmol/L NaOH at 80°C for 1 hr, and then centrifuged for 20 min at 16,000 g. The supernatants were placed into a 96-well microplate, and absorbance was measured at 405 nm-a wavelength at which melanin absorbs light.
The ratio of melanin to cell numbers in the control group (the same cells but not treated with puerarin) was normalized to 100% for each assay, and treatments were expressed as the percentage of the controls.
| Cellular TYR activity assay
Cellular TYR activity was measured using a previously described method (Hwang et al., 2013) . The cells were cultured at a density of 1 × 10 5 cells in T-25 flasks for 48 hr. After 24-hr incubation with puerarin, the cells were lysed with phosphate buffer (pH 6.8) containing 1% Triton X-100. The cells were then disrupted by freeze-thawing, and lysates were clarified by centrifuging at 10,000 g for 5 min. After quantifying protein levels and adjusting concentrations with lysis buffer, 100 μl of each protein solution was put in a 96-well plate, and the enzymatic assay was initiated by the addition of 40 μl of L-DOPA (2 mg/ml) solution at 37°C. Absorbance was measured every 10 min for at least 1.5 hr at 475 nm using a microplate reader. TYR activity was expressed as the percentage of the controls (melanocytes without puerarin treatment).
| Western blotting
The proteins were extracted from melanocytes using RIPA lysis buffer.
Lysates were sonicated on ice and centrifuged at 12,000 rpm for 30 min at 4°C. The protein concentration was determined by the Bradford method using bovine serum albumin (BSA) as the standard.
The total cellular protein was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene fluoride (PVDF) membrane. The blots were incubated in blocking buffer (5% nonfat milk in Tris-buffered saline containing 10-mM Tris, pH 7.5, 100-mM NaCl) at room temperature for 3 hr and then at 4°C overnight with antibodies. Master Mix (Applied Biosystems), 60 ng of cDNA, and 2 μmol of gene-specific primer sets (Macrogen, Seoul). The primers used were showed as followed: TYR 5′-GATGAGTACATGGGAGGTCAGC-3′
(forward) and 5′-GTACTCCTCCAATCGGCTACAG-3′ (reverse), TRP2
5′-AGATTGCCTGTCTCTCCAGAAG-3′ (forward) and 5′-CTTGAG AATCCAGAGTCCCATC-3′ (reverse), MITF 5′-GTA TGAACACGCAC TCTCGA-3′ (forward) and 5′-GTAACGTATTTGCCATTT-3′ (reverse), and GAPDH (NM_002046.3) 5′-ATGGGGAAGGTGAAGGTCG-3′
(forward) and 5′-GGGGTCATTGATGGCAACAA-3′ (reverse). Reactions were performed using the following protocol: initial incubation at 50°C for 2 min, DNA polymerase activation at 95°C for 10 min, 40 cycles of denaturation at 95°C for 15 s, and annealing and extension at 60°C for 1 min. The expression levels of mRNA corresponding to TYR, TRP2, and MITF were evaluated relative to levels of an internal control, GAPDH mRNA, and were calculated using the comparative threshold cycle method.
| Mice vitiligo models
Female SPF C57BL/6 mice at 4 weeks of age were purchased from Animal Center of Chinese Academy of Sciences, Shanghai, China.
The protocol for animal care and use conformed to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and was approved by the Animal Care and Use Committee of Wenzhou Medical University. The vitiligo mice were induced as previously described (Zhu, Wang, & Xu, 2013) . In brief, mice accepted 40% monobenzone cream (4-benzyloxyphenol, Sigma) on the 2 × 2 cm shaved abdomen. Creams were completely massaged in using a spatula. The cream was withdrawn on Day 50, and observation was continued until Day 65. Mice in the control group were treated with petrolatum for 50 days.
| Experimental animal design
The mice were randomly divided into three groups of 10 mice to establish a normal mice control group (CL), a vitiligo mice model group, and a vitiligo mice with puerarin treatment group. Vitiligo mice in the puerarin group were injected with 100-mg/kg puerarin (chemical structure presented in Figure 1 ; Sigma-Aldrich, St. Louis, MO, USA) in 20% propanediol via the tail vein daily for 7 days (Wang et al., 2016) . Mice in the control and model groups were injected with same volume of saline. Food and water were available. Mice were maintained under a constant temperature of 20 ± 2°C, a relative humidity of 50% ± 10%, and a 12-hr light/dark cycle.
| Histological analysis
Depigmentation skin sections distant from the monobenzone application site were obtained and fixed in 4% paraformaldehyde for 24 hr at 4°C. After that, the samples were dehydrated through an alcohol gradient, cleared, and embedded in paraffin blocks. Paraffin wax tissue blocks were sectioned at 6 mm, and then hematoxylin and eosin (HE) staining was performed. The detail methods were described previously (Stewart, Ajao, & Ihunwo, 2013) . To further distinguish the differences between the various groups, Lillie staining was also performed.
| Statistical analysis
To verify the statistical significance, the mean ± standard deviation of three independent measurements was calculated. A value of Figure 1a ,b. After DOPA staining, melanocytes in the shape of dendritic structure stained by DOPA can be observed (Figure 1c,d) , whereas KCs and fibroblasts cannot be stained.
| Effects of puerarin on cell viability
To investigate the effect of puerarin in human melanocytes viability and proliferation, human melanocytes were treated with puerarin at various concentrations (1-160 μmol/L) for 24 hr or were kept as an untreated control, and the cell viability was analyzed by the CCK-8 assay. As shown in Figure 1f , the effects in the control cells treated only with ordinary culture medium (CL) were assigned 100%. The highest melanocyte proliferation rate was observed when the concentration was 40 μmol/L. However, the cell viability decreased by approximately 50% at a concentration of 80 μmol/L. On the basis of this observation, the experiment of melanin content was performed by treating cells with puerarin at various concentrations (1-40 μmol/ L) to investigate its effect on melanogenesis in melanocytes.
| Effects of puerarin on melanin production in human melanocytes
To study the effect of puerarin on melanogenesis in human melanocytes, we examined the level of melanin produced in human melanocytes after treating the cells with puerarin at various concentrations (1-40 μmol/L) for 24 hr, as well as with the ordinary culture medium as the control. As shown in Figure 2a , puerarin significantly increased melanin content at the concentration of 40 μmol/L, at which the subsequent experiment was performed.
| Effects of puerarin on cellular TYR activity in human melanocytes
TYR is involved in the first two key steps of melanogenesis. Therefore, we measured the intracellular activity of TYR to clarify the mechanism for the stimulation of melanin synthesis. Human melanocytes were kept as controls or were treated with puerarin at 40 μmol/L for 24 hr. As shown in Figure 2b , puerarin stimulated TYR activity compared with the level of the control cells. The results suggested that 
| Effects of puerarin on protein expression of TRP-1 and MITF
Melanogenesis is regulated by an enzyme cascade that includes TYR and TRP-1, whereas MITF can upregulate TYR and TRP-1 protein expression. MITF is a key transcription factor that modulates the expression of melanogenic genes. In order to investigate whether puerarin can influence melanogenic protein expression, western blotting analysis was carried out using the lysate of melanocytes stimulated by puerarin (40 μmol/L) for 24 hr. As shown in Figure 2c , addition of puerarin to the melanocytes led to the promotion of TRP-1 and MITF expression. These results suggested that the upregulation of melanin synthesis by puerarin could be due to the increased expression levels of TRP-1 and MITF.
| Effects of puerarin on gene expression of TYR, TRP-1, and MITF
The effects of puerarin on the expression of mRNA corresponding to melanogenic enzymes were evaluated at the concentration of 40 μmol/L. Total cellular mRNA was extracted, and the mRNA levels of TYR, TRP-1, and MITF were determined by quantitative reverse transcription PCR. As shown in Figure 2d , puerarin markedly increased the mRNA expression of TYR, TRP-1, and MITF.
| The effect of puerarin on MAPK pathways in human melanocytes
MAPKs signaling pathways regulate a wide range of biological processes including proliferation, survival, migration and invasion, and differentiation. To further understand the mechanism of puerarin on melanogenesis, the MAPKs pathways were detected on western blot. Puerarin decreased the phosphorylation of ERK. No other effect was observed on the phosphorylation of P38 and JNK (Figure 3a,b) .
| The treatment effect of puerarin in vitiligo mice model
After topical application of monobenzone cream, small white patches first appeared in the drug-exposed area and gradually expanded.
Distant white patches (depigmentation on the nonexposed sites) were found on the trunk, ears, and/or tail of some mice after prolonged treatment (Figure 3c ). The white patches expanded over time, with the possibility of ultimately resulting in substantial depigmentation over most parts of the body. No white patches in the control group.
Mice in the puerarin group were injected with 100-mg/kg puerarin in 20% propanediol via the tail vein daily for 7 days. Mice in the control and model groups were injected with same volume of saline.
Depigmentation skin sections distant from the monobenzone application site were obtained from model and puerarin groups; corresponding sites were gained from the CL group. As shown in Figure 4 , HE staining showed that the dorsal epidermis of normal mice was very thin, and no melanocytes were distributed. The dermis and subcutaneous tissues were similar to human. The difference was that the number of hair follicles was more in mice skin and the distribution of dense melanin around the hair follicles. In vitiligo mice, there were no melanocytes in the basal layer. The number of hair follicles also decreased compared with the normal mice, and there was no melanin distribution around the hair follicles. The number of hair follicles in the puerarin group was significantly higher than that in the vitiligo group; the distribution of melanin around the hair follicle was obvious.
The staining of melanin with Lillie staining was obvious, and the distribution of hair follicles in each group was consistent with that of HE staining.
FIGURE 3 (a) Effect of puerarin on ERK1/2, p38, and JNK expression and phosphorylation. Human melanocytes were cultured in the presence of puerarin (40 μmol/L) for 24 hr. Cells were harvested, and proteins were subjected to western blotting against ERK1/2, p-ERK1/2, p38, p-p38, JNK, and p-JNK. Densities were quantified with ImageJ software. Values represent mean ± SD of three independent experiments; 
| DISCUSSION
Vitiligo is an acquired cutaneous disorder of pigmentation, characterized as chalky-white macules or patches, and the pathogenesis is still not exact, whereas the destruction of melanocytes and the subsequent depigment in the skin lesion has been suggested to be the key event (Ghafourian et al., 2014) . Melanin synthesis in the skin plays an important evolutionary role in hypopigmentation therapy.
Melanin biosynthesis is catalyzed by three melanocyte specific enzymes: TYR, TRP-1, and TRP-2 (Nakagawa, 2006) . TYR is the rate-limiting enzyme in melanogenesis (Park et al., 2004) , catalyzing the hydroxylation of tyrosine to produce DOPA and the oxidation of DOPA to DOPA quinone. TRP-1 and TRP-2 function in the biosynthesis of melanin downstream of TYR (Nakagawa, 2006) . MITF has a crucial role in the transcription of melanogenic genes, binding highly conserved motif termed M-box within the TYR promoter.
Therefore, MITF plays an important role in increasing melanogenesis (Hearing, 1999; Screaton et al., 2004) . Puerarin was found to upregulate melanin synthesis and MITF transcription via increasing the intracellular cAMP levels in melan-a cell. Furthermore, puerarin stimulated the expression of TYR, TRP-2, resulting in increased melanin synthesis and the survival of melanocytes . Consistently, our results revealed that puerarin could increase the melanin content and the TYR activity in human melanocytes at the concentration of 40 μmol/L. Furthermore, several studies have shown that the MAPK pathways (ERK, JNK, and p38) are involved in the regulation of MITF activity (Bu et al., 2008; Kim et al., 2014) . As mentioned in Section 1, phosphorylation of MAPK (including ERK, JNK, and p38 MAPKs) has been reported as one of the signaling processes in hyperpigmentation (Park & Gilchrest, 1999) . It has been shown that p38 MAPK activates MITF through the phosphorylation of cAMP responsive element binding, which in turn upregulates the expression of TYR, TRP-1, and TRP-2, resulting in melanin production (Bellei et al., 2010) . Activations of the ERK signaling (Kim et al., 2007) and the JNK/SAPK pathways (Bu et al., 2008) are related to the downregulation of melanogenesis.
In our experiments, treatment with puerarin did not affect the total protein levels of ERK, JNK, or p38. Our data revealed that puerarin inhibited phosphorylation and activation of ERK, resulting in the upregulation of MITF as well as TYR and TRP-1, whereas no significant differences were observed in p38 and JNK phosphorylation. Thus, the inhibition of the ERK signaling pathway likely plays a pivotal role in puerarin-induced melanogenesis.
In previous research, puerarin was reported to stimulate the melanogenesis via cAMP/MITF-M signaling pathway in vitro and prevent the follicular depigmentation and vitiligo by stimulating melanin synthesis in MITFvit/vit mice . At present, there are few in vivo experiments of vitiligo mice. In order to make this study more clinically meaningful, we designed related animal experiments. First, we developed vitiligo mouse models by monobenzone cream. According to the staining results, we found that the number of hair follicles in the puerarin group was significantly higher than that in the vitiligo group, the distribution of melanin around the hair follicle was obvious. The staining of melanin with Lillie staining was obvious, and the distribution of hair follicles in each group was consistent with that of HE staining. Subsequently, the mice were randomly divided into three groups of 10 mice to establish a normal mice control group (CL), a vitiligo mice model group, and a vitiligo mice with puerarin treatment group. Vitiligo mice in the puerarin group were injected with 100-mg/kg puerarin in 20% propanediol via the tail vein daily for 7 days (Wang et al., 2016) . Mice in the control and model groups were injected with same volume of saline. The number of hair follicles in the puerarin group was significantly higher than that in the vitiligo group; the distribution of melanin around the hair follicle was obvious.
Above all, we concluded that puerarin could increase the cell proliferation and upregulate the melanin synthesis of human melanocytes via ERK signaling pathway at the concentration of 40 μmol/L at the cellular level. Additionally, puerarin also had certain therapeutic effect FIGURE 4 Staining results. HE staining results are consistent with the Lillie staining. The number of hair follicles in the puerarin group was significantly higher than that in the vitiligo group; the distribution of melanin around the hair follicle was obvious. HE: hematoxylin and eosin [Colour figure can be viewed at wileyonlinelibrary.com] on vitiligo mice in vivo. Thus, puerarin may be a possible medicine of vitiligo therapy in clinical.
